Jonathan Weiss

Jonathan Weiss

Stellate Therapeutics SAS - Paris / France
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4982801
person_outline Jonathan Weiss's MOST POPULAR ARTICLES
1-) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells JM Weiss, AM Bilate, M Gobert, Y Ding, MA Curotto de Lafaille, ... Journal of Experimental Medicine 209 (10), 1723-1742, 2012 6822012
2-) Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism A Zanin-Zhorov, JM Weiss, MS Nyuydzefe, W Chen, JU Scher, R Mo, ... Proceedings of the National Academy of Sciences 111 (47), 16814-16819, 2014 1892014
3-) Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism R Flynn, K Paz, J Du, DK Reichenbach, PA Taylor, A Panoskaltsis-Mortari, ... Blood, The Journal of the American Society of Hematology 127 (17), 2144-2154, 2016 1452016
4-) ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host diseaseM Jagasia, A Lazaryan, CR Bachier, A Salhotra, DJ Weisdorf, B Zoghi, ...Journal of Clinical Oncology 39 (17), 1888-1898, 20211332021
5-) Cutting edge: selective oral ROCK2 inhibitor reduces clinical scores in patients with psoriasis vulgaris and normalizes skin pathology via concurrent regulation of IL-17 and IL-10A Zanin-Zhorov, JM Weiss, A Trzeciak, W Chen, J Zhang, MS Nyuydzefe, ...The Journal of Immunology 198 (10), 3809-3814, 2017952017